Test Price
2,800 AED✅ Home Collection Available
COL6A3 Gene Genetic Test for Bethlem Myopathy Type 1 in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين COL6A3 للاعتلال العضلي من نمط بيثليم 1 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
يضمن تحليل الجين COL6A3 بتقنية التسلسل الجيني المتقدم (NGS) دقة تشخيصية تصل إلى 99.9% وفقًا لمعايير هيئة الصحة بدبي (DHA) وشهادة ISO 9001:2015 (رقم الشهادة INT/EGQ/2509DA/3139).
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid hospital-grade home collection (8 AM–11 PM) with ISO-certified cold-chain transport and VIP mobile phlebotomy.
- Clinical Guidance: Complimentary post-test telephonic result interpretation by a DHA-licensed neurologist.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Overview
The COL6A3 gene next‑generation sequencing test identifies pathogenic variants in COL6A3 associated with Bethlem myopathy type 1, a hereditary collagen VI‑related neuromuscular disorder. This analysis empowers neurologists, clinical geneticists, and paediatric neurologists to confirm diagnosis, guide management, and screen at‑risk family members with the highest available resolution.
| Feature | Our Test (COL6A3 NGS) | Closest Alternative |
|---|---|---|
| Method | Full‑gene NGS (Illumina NovaSeq X Plus) with CNV detection | Targeted mutation panel (limited exons) |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Diagnostic Sensitivity | 99.9% for single nucleotide variants & structural rearrangements | ~85% (misses deep intronic & novel variants) |
| Suitable for | Pre‑natal, paediatric, adult, and carrier screening | Symptomatic only |
Physician Insight & Safety Protocol
“As a consultant neurologist (DHA License: 61713011), I stress that genetic testing must always be paired with a complete neuromuscular evaluation and family history. A positive COL6A3 result confirms the molecular diagnosis but is not a substitute for clinical judgement; every finding requires careful correlation with the patient’s symptoms and disease course.” – Dr. Prabhakar Reddy
⚠ Important Medication & Safety Notice
Do not discontinue prescribed medication without consulting your doctor. Altering treatment based solely on a genetic test result can lead to disease exacerbation or life‑threatening complications.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Blood transfusion within the last 4 weeks, active immunomodulatory therapy (e.g., high‑dose steroids, biologics) that may compromise DNA integrity, or inability to provide informed consent. For minors, written legal‑guardian consent is required per UAE CDS Law 2026.
- Red Flags: Sudden worsening of muscle weakness, difficulty breathing, swallowing issues, or palpitations – seek emergency care immediately. These are not related to the blood draw but indicate possible disease progression.
Patient FAQ & Clinical Guidance
1. How long does the COL6A3 genetic test take and what does the 2800 AED cover?
The full‑gene NGS analysis of COL6A3 for Bethlem myopathy type 1 is completed in 3 to 4 weeks, and the 2800 AED fee includes expert venipuncture, cold‑chain transport, sequencing, bioinformatics interpretation, and a post‑test teleconsultation with a DHA‑licensed neurologist.
كم يستغرق تحليل جين COL6A3 وماذا يشمل سعر 2800 درهم؟
2. Can I use a finger‑prick sample or an FTA card instead of a full blood draw?
Yes, we accept one drop of blood on an FTA card, extracted DNA, or a standard whole blood sample – all are validated for the NGS workflow and are collected by our mobile phlebotomy team under ISO‑certified conditions.
هل يمكنني استخدام عينة وخز الإصبع أو بطاقة FTA؟
3. Is this test suitable for children and does the result affect treatment?
The is approved for all ages, including newborns, when accompanied by a paediatric neurologist’s referral; the result provides a precise molecular diagnosis that informs rehabilitative strategies, orthopaedic monitoring, and family planning, but any treatment changes must be made by your supervising physician.
هل يناسب هذا الفحص الأطفال؟
UAE Regulatory Compliance
This service adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87) on medical data privacy, the CDS Law 2026 for minor consent, and UAE PDPL standards. All processing takes place in a facility holding ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) with DHA license #9834453. Genetic counselling is mandatory before sample collection.
For appointments or insurance queries, contact +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians